)
Claudia Wurzenberger
VP, Head of Antibody Discovery and Project Management,
Ampersand Biomedicines
Claudia Wurzenberger currently serves VP, Head of Antibody Discovery and Project Management at Ampersand Biomedicines. She has broad expertise in managing and executing projects for the discovery and preclinical development of therapeutic proteins in different disease areas, including immuno-oncology, inflammatory and respiratory diseases. Prior to joining Ampersand, Claudia was a Project Leader at Pieris Pharmaceuticals, leading several internal and partnered programs from early discovery into IND-enabling studies. Her experience also includes serving as Senior Scientist at Immunocore Ltd.
Sessions